Clinical trials of human lung surfactant from amniotic fluids in neonatal respiratory distress syndrome

О. А. Rosenberg; A. G. Antonov; N. N. Volodin; V. A. Volchkov; O. B. Milenin; I. I. Rumina; Ed. K. Tsybulkili

doi:10.17816/JOWD101367

Journal of obstetrics and women's diseases ›› 1999, Vol. 48 ›› Issue (5S) : 130 -130. DOI: 10.17816/JOWD101367

Articles

oration

Clinical trials of human lung surfactant from amniotic fluids in neonatal respiratory distress syndrome

Author information +

History +

PDF (264KB)

Abstract

Objective: Estimation of the efficiency, tolerance and safety of «Surfactant-HL» (ST-HL) (CRIRR, St. Petersburg, Russia) for treatment of neonatal respiratory distress syndrome (NRDS) was performed in 5 Russian neonatal departments in Moscow and St. Petersburg.

Keywords

lung surfactant / amniotic fluids / neonatal respiratory distress syndrome / clinical trials

Cite this article

Download citation ▾

О. А. Rosenberg, A. G. Antonov, N. N. Volodin, V. A. Volchkov, O. B. Milenin, I. I. Rumina, Ed. K. Tsybulkili. Clinical trials of human lung surfactant from amniotic fluids in neonatal respiratory distress syndrome. Journal of obstetrics and women's diseases, 1999, 48(5S): 130-130 DOI:10.17816/JOWD101367